These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18786487)
1. New light on an old problem photodynamic therapy for atherosclerosis. Muller JE J Am Coll Cardiol; 2008 Sep; 52(12):1033-4. PubMed ID: 18786487 [No Abstract] [Full Text] [Related]
3. A brief overview of photodynamic therapy in Europe. Mitton D; Ackroyd R Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):103-11. PubMed ID: 19356640 [TBL] [Abstract][Full Text] [Related]
4. Target-selective degradation of cancer-related proteins by novel photosensitizers for molecular-targeted photodynamic therapy. Toshima K; Tanimoto S; Tsumura K; Umezawa K; Takahashi D Cancer Sci; 2009 Sep; 100(9):1581-4. PubMed ID: 19522852 [TBL] [Abstract][Full Text] [Related]
5. Directed evolution of light-activated drugs. Hall K Med Hypotheses; 1999 Dec; 53(6):504-6. PubMed ID: 10687892 [TBL] [Abstract][Full Text] [Related]
6. [Photodynamic therapy of malignant tumors]. Jirsa M Sb Lek; 1996; 97(1):115-34. PubMed ID: 8711408 [No Abstract] [Full Text] [Related]
7. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment. Busch T Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798 [TBL] [Abstract][Full Text] [Related]
13. Trisulfonated porphyrazines: new photosensitizers for the treatment of retinal and subretinal edema. van Lier JE; Tian H; Ali H; Cauchon N; Hasséssian HM J Med Chem; 2009 Jul; 52(14):4107-10. PubMed ID: 19514748 [TBL] [Abstract][Full Text] [Related]